Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Lipid peroxidation worsens skin diseases but may help treat cancer.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Syphilis can cause hair loss and skin changes in HIV-positive patients, and proper treatment can resolve these symptoms.